Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 25 Neoplasms 12 Stomach Neoplasms 10 Endometrial Neoplasms 10 Lung Neoplasms 9 Lymphatic Metastasis 7 Melanoma 6 Head and Neck Neoplasms 6 Carcinoma, Hepatocellular 6 Uterine Cervical Neoplasms 5 Rectal Neoplasms 5 Esophageal Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Vulvar Neoplasms 3 Sarcoma 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Colorectal Neoplasms 3 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Skull Base Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Peritoneal Neoplasms 2 Osteosarcoma 2 Margins of Excision 2 Lymphedema 2 Hypoparathyroidism 2 Giant Cell Tumor of Bone 2

Interventions

Bupivacaine 3 Lidocaine 2 Botulinum Toxins, Type A 2 Ultrasonography 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Radiofrequency Ablation 1 Nerve Conduction Studies 1 Musculoskeletal Manipulations 1 Methylprednisolone 1 Injections 1 Indocyanine Green 1 Electromyography 1 Dry Needling 1 Decompression 1 Cryosurgery 1 Cholecalciferol 1 Bevacizumab 1 Anesthetics, Local 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neuroma × Indocyanine Green × Clear all

NCT06164392 2025-01-01

Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography

Northwestern University

Phase 4 Withdrawn

Neuroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡